The Patent Finder

Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping

Avidity Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2018/012672, filed Jan 5, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,994,020Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
In force
 · Low confidence
Avidity Biosciences LLCIn force
Low confidence
US 11,179,472Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
In force
 · Low confidence
Avidity Biosciences LLCIn force
Low confidence
US 11,311,627Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
In force
 · Low confidence
Avidity Biosciences, Inc.In force
Low confidence
US 11,400,163Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
In force
 · Low confidence
Avidity Biosciences, Inc.In force
Low confidence
US 12,064,483Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
In force
 · Low confidence
Avidity Biosciences, Inc.In force
Low confidence
Application 18/770,359Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
Pending
Not granted
Avidity Biosciences, Inc.PendingNot granted
Application 19/031,231Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
Pending
Not granted
Avidity Biosciences, Inc.PendingNot granted
Application 19/312,209Nucleic Acid-Polypeptide Compositions and Methods of Inducing Exon Skipping
Pending
Not granted
Avidity Biosciences, Inc.PendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Avidity Biosciences, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited